Global Regenerative Medicines Market Report 2017

Dublin, Oct. 24, 2017 -- The "Global Regenerative Medicines Market" report has been added to Research and Markets' offering.

Regenerative medicine is a branch of medicine involved with the repair or replacement of damaged tissues or organs. The field uses various strategies like the cell therapy, gene therapy and tissue engineering among others to replace the missing or damaged tissue or organ.

These also include the implantable medical devices. Regenerative medicine offers a treatment option for the incurable diseases such as cardiac diseases, immune-oncology and orphan diseases among others.

The gene therapy involves modulation of the target gene. It involves either the replacement, modification, silencing or introduction of the desired gene into the patient's body. Gene therapy may be done in vivo, where the gene is transferred to cells inside the body.

It may also be done ex vivo where the gene is incorporated into the cells outside the body which are then transferred into the patient's body. Cell therapy involves the administration of living non genetically modified cells into the patient's body. These cells multiply to replace or repair the damaged organ or tissue.

The cells used could be allogenic or autogenic. Tissue engineering technique involves biomaterials, biologically active molecules, cells, tissues or scaffolds.

Key Topics Covered:

Executive Summary

1 Report Scope

2 Market Overview

3 Market Dynamics

4 Competitive Insights

5 Industry Insights

• Regulatory Scenario
• Patent Landscape

6 Global Regenerative Medicine Market, By Therapy

• Cell Therapy
• Gene Therapy
• Tissue Engineering

7 Global Regenerative Medicine Market, by Product

8 Global Regenerative Medicine Market, By Application

• Orthopaedic
• Cardiology
• Wound Healing
• Diabetes
• Immuno-Oncology
• Others

9 Global Regenerative Medicine Market, By Geography

10 Company Profiles

• Acelity
• Athersys
• Cellular Biomedicine Group
• Cytori Therapeutics Inc.
• Integra LifeSciences
• Mesoblast
• MiMedx
• Novartis AG
• Nuvasive
• Organogenesis
• Osiris Therapeutics
• Stryker
• Terumo Corporation
• TiGenix
• Tissue Regenix
• Vericel Corporation
• Viacyte
• Zimmer Biomet

For more information about this report visit https://www.researchandmarkets.com/research/wsw6m5/global

CONTACT: Research and Markets
         Laura Wood, Senior Manager
         [email protected]
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         Related Topics: Biopharmaceuticals